Press release
Rising Prevalence Of Cardiovascular Diseases And The Structural Heart Device Market: Major Factor in the Transformation of the Structural Heart Devices Market in 2025
Structural Heart Devices Market Size
The size of the structural heart devices market has seen substantial expansion in the past few years. The industry which stood at $10.41 billion in 2024 is forecasted to rise to $11.44 billion in 2025, representing a compound annual growth rate (CAGR) of 9.9%. The acceleration in this historical timeframe arises from factors such as the gravitation towards less obtrusive surgical procedures, the surge in demand for minimally invasive structural heart devices, continuous learning and development programs for healthcare practitioners, an increase in healthcare spending, and escalating patient inclination for non-surgical or slightly invasive treatment alternatives.
There is an anticipation of robust growth in the structural heart devices market in the upcoming years. The market is forecasted to swell to $16.48 billion by 2029 with a 9.6% CAGR. The predicted growth for this period is due to factors such as a rise in the elderly population, heightened awareness concerning cardiac health, initiation of screening programs, advantageous reimbursement policies for structural heart procedures, and prompt regulatory approval for novel structural heart devices. Noteworthy trends for this forecast period encompass a rise in the uptake of transcatheter valve replacement, continuous invention of breakthrough devices utilizing advanced materials, augmented focus on personalized treatment plans, a growth in the adoption of hybrid procedures and the incorporation of remote monitoring coupled with telehealth solutions.
What Key Elements Are Boosting Growth in the Structural Heart Devices Market?
The increase in cardiovascular diseases is anticipated to fuel the expansion of the structural heart device market in the future. Cardiovascular diseases (CVDs) encompass conditions that affect the heart and blood vessels, including coronary artery disease, heart attacks, and strokes. There has been a gradual global rise in such conditions, due to factors like inactive lifestyles, poor eating habits, increased obesity, smoking, and older populations. Structural heart devices can treat cardiovascular diseases by mending or replacing defective heart valves, rectifying structural flaws, and enhancing heart function as well as patient outcomes. For instance, data released by the British Heart Foundation, a UK-based cardiovascular research charity, stated that as of September 2024, about 7.6 million people in the UK are suffering from heart and circulatory diseases. This includes approximately 4 million men and 3.6 million women. These diseases account for around 27% of all deaths in the UK, resulting in over 170,000 fatalities each year, or about 480 deaths daily, which equates to a death every three minutes. Consequently, the growing occurrence of cardiovascular diseases is accelerating the expansion of the structural heart device market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp
Who Are the Major Industry Players Fueling Structural Heart Devices Market Expansion?
Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.
Which Key Developments Are Influencing the Structural Heart Devices Market?
Leading players within the structural heart devices market are pioneering minimally invasive treatment methods and devices to boost patient results, diminish recuperation periods, and broaden treatment alternatives for structural heart conditions. A self-expanding transcatheter aortic valve implantation (TAVI) system, designed to lodge and secure the replacement valve within the native aortic valve structure without depending on balloon inflation, is one such device. In December 2022, for instance, Abbott Laboratories, a Company rooted in the US manufacturing medical devices and health care products, unveiled its newest transcatheter aortic valve implantation (TAVI) system, Navitor, in India. This system is custom-made for patients at high or extreme surgical risk suffering from severe aortic stenosis. Its advanced features include a distinctive design to prevent valve leakage. Navitor strengthens Abbott's structural heart transcatheter range, providing physicians and patients with minimally invasive treatment alternatives for heart diseases. It is the only self-expanding TAVI system featuring intra-annular leaflets and large frame cells, improval promoting access to coronary arteries for prospective future interventions in coronary artery disease (CAD). This innovative design further boosts hemodynamics, facilitating optimal blood flow.
How Is the Segmentation of the Structural Heart Devices Market Defined?
The structural heart devices market covered in this report is segmented -
1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems
2) By Procedure: Replacement Procedures, Repair Procedures
3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications
4) By Age Group: Pediatric, Adults
Subsegments:
1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings
2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings
3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders
4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report
What Is the Leading Region in the Structural Heart Devices Market?
North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Structural Heart Devices Global Market Report?
- Market Size Analysis: Analyze the Structural Heart Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Structural Heart Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Structural Heart Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Structural Heart Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15677
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Cardiovascular Diseases And The Structural Heart Device Market: Major Factor in the Transformation of the Structural Heart Devices Market in 2025 here
News-ID: 3866472 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
